Skip to main content

Find Clinical Trials

Home
Conditions
Bioequivalence

Clinical trial condition

Bioequivalence

Explore clinical trials studying Bioequivalence. Study availability and eligibility vary by location and protocol.

143 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Bioequivalence trial results

Completed

Bioavailability Study in Healthy Participants, 200mg Tablets ZSP1273 Versus 200mg Granules ZSP1273

NCT06164431

Conditions: Bioequivalence
Locations: Guangdong Hospital of Chinese Medicine Guangzhou, Guangdong, China

View Trial Details

Completed

Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions

NCT05642845

Conditions: Bioequivalence
Locations: State Budgetary Healthcare Institution of the Yaroslavl Region "Clinical Hospital No. 2" Yaroslavl, Russia

View Trial Details

Completed

Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions

NCT05685277

Conditions: Bioequivalence
Locations: Separate medical division "Comed" (Ligand Research LLC) Moscow, Russia

View Trial Details

Completed

Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy Adult Subjects Under Fasting Conditions

NCT04038008

Conditions: Bioequivalence
Locations: Altasciences Company Inc. Mount Royal, Quebec, Canada

View Trial Details

Completed

Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions

NCT05934799

Conditions: Bioequivalence
Locations: State Autonomous Healthcare Facility of the Yaroslavl Region "Clinical Hospital No. 2" Yaroslavl, Yaroslavl Oblast, Russia

View Trial Details

Completed

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

NCT06124573

Conditions: Bioequivalence, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Avant Santé Research Center S.A. de C.V. San Pedro Garza García, Nuevo León, Mexico

View Trial Details

Completed

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

NCT06124547

Conditions: Bioequivalence, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Avant Santé Research Center S.A. de C.V. San Pedro Garza García, Nuevo León, Mexico

View Trial Details

Completed

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

NCT06124495

Conditions: Bioequivalence, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Avant Santé Research Center S.A. de C.V. San Pedro Garza García, Nuevo León, Mexico

View Trial Details

Completed

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

NCT06124560

Conditions: Bioequivalence, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Avant Santé Research Center S.A. de C.V. San Pedro Garza García, Nuevo León, Mexico

View Trial Details

Completed

A Phase 1 Bioequivalence Study of Efgartigimod PH20 SC Administered Via a Prefilled Syringe Versus a Vial+Syringe Presentation in Healthy Adults

NCT05817435

Conditions: Bioequivalence
Locations: Investigator site 0010209 Tempe, Arizona, United States

Investigator site 0010208 Lincoln, Nebraska, United States

View Trial Details